229 related articles for article (PubMed ID: 67817)
1. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS; Winokur SH
Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drug-induced lung disease.
Sostman HD; Matthay RA; Putman CE
Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
[TBL] [Abstract][Full Text] [Related]
3. The action of antitumor agents: a double-edged sword?
Sieber SM
Med Pediatr Oncol; 1977; 3(2):123-31. PubMed ID: 327250
[TBL] [Abstract][Full Text] [Related]
4. Lung damage from cytotoxic drugs.
Collis CH
Cancer Chemother Pharmacol; 1980; 4(1):17-27. PubMed ID: 6153937
[TBL] [Abstract][Full Text] [Related]
5. Use of anticancer drugs during pregnancy.
Stutzman L; Sokal JE
Clin Obstet Gynecol; 1968 Jun; 11(2):416-27. PubMed ID: 4879373
[No Abstract] [Full Text] [Related]
6. Cytotoxic drug-induced pulmonary disease: update 1980.
Weiss RB; Muggia FM
Am J Med; 1980 Feb; 68(2):259-66. PubMed ID: 6153504
[TBL] [Abstract][Full Text] [Related]
7. Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
Jaffe N
Pediatr Clin North Am; 1976 Feb; 23(1):233-44. PubMed ID: 768885
[No Abstract] [Full Text] [Related]
8. Hepatic and pancreatic damage produced by cytotoxic drugs.
Woolley PV
Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
[No Abstract] [Full Text] [Related]
9. Effects of immunosuppressive drugs during pregnancy.
Bermas BL; Hill JA
Arthritis Rheum; 1995 Dec; 38(12):1722-32. PubMed ID: 8849343
[No Abstract] [Full Text] [Related]
10. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
11. [Fetal risk of cancer chemotherapy (author's transl)].
Schaison G; Jacquillat C; Auclerc G; Weil M
Bull Cancer; 1979; 66(2):165-70. PubMed ID: 465749
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic tissue damage and immunosuppression].
Holm O
Lakartidningen; 1976 Apr; 73(17):1624-8. PubMed ID: 1083468
[No Abstract] [Full Text] [Related]
13. [Hair changes in immunosuppressive therapy].
Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
[No Abstract] [Full Text] [Related]
14. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of immunosuppressive drugs in man.
Decker JL
Arthritis Rheum; 1973; 16(1):89-91. PubMed ID: 4734960
[No Abstract] [Full Text] [Related]
16. Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.
Sieber SM; Adamson RH
Adv Cancer Res; 1975; 22():57-155. PubMed ID: 766582
[No Abstract] [Full Text] [Related]
17. [Drug side effects in antineoplastic and immunosuppressive cytostatic therapy].
Hambsch K; Fischer H
Z Gesamte Inn Med; 1984 Jan; 39(1):7-14. PubMed ID: 6711064
[TBL] [Abstract][Full Text] [Related]
18. Strategies for preservation of ovarian and testicular function after immunosuppression.
Pendse S; Ginsburg E; Singh AK
Am J Kidney Dis; 2004 May; 43(5):772-81. PubMed ID: 15112167
[TBL] [Abstract][Full Text] [Related]
19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
20. Bar-shaped nuclear bodies in oral epithelial cells of children receiving chemotherapy for cancer.
Stern MH; Curtis AB
Arch Oral Biol; 1971 Oct; 16(10):1241-3. PubMed ID: 5289683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
